Experts, lawmakers express support for select drug patent reforms
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesPharmaceuticalsProduct LifecycleUnited StatesRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesPharmaceuticalsProduct LifecycleUnited States